Literature DB >> 32346131

Are single-donor red blood cell transfusions still relevant for preterm infants?

Elodie Gouache1, Jean-Yves Py2, Béatrice Hérault3, Elie Saliba1,4, Geraldine Favrais5,6.   

Abstract

OBJECTIVE: To explore the worth of a single-donor program for preterm infants through the recipient profile and the impact on donor exposure, red blood cell (RBC) pack waste, storage duration, and transfusion performance. STUDY
DESIGN: Patients and transfusion characteristics were collected for 3 years (2015-2017) in preterm infants according to single-donor program prescription in a unit not practicing placental transfusion or erythropoietin supplementation.
RESULTS: Among 1048 eligible preterm infants, 161 met the inclusion criteria, and 51 received single-donor packs. Our single-donor program induced a donor number reduction (34% less than the transfusion number) and an extension of storage duration (median: 9 versus 7 days, p < 0.0001) without altering the transfusion performance. However, 41% of small packs were not used.
CONCLUSION: A single-donor program partially reduced donor exposure but led to drastic RBC pack waste. Optimization of transfusion alternatives may increase this phenomenon, calling into question the rationale of this practice.

Entities:  

Year:  2020        PMID: 32346131     DOI: 10.1038/s41372-020-0670-9

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  2 in total

Review 1.  Early erythropoiesis-stimulating agents in preterm or low birth weight infants.

Authors:  Arne Ohlsson; Sanjay M Aher
Journal:  Cochrane Database Syst Rev       Date:  2017-11-16

2.  Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants.

Authors:  Sanjay M Aher; Arne Ohlsson
Journal:  Cochrane Database Syst Rev       Date:  2019-02-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.